In addition, we present an in silico analysis of the sensitivity of a large panel of human cancer cell lines to the knockdown or knockout of SNRPD2; of genes and biological processes that have SNRPD2-like effects on the viability of these cancer cells; and of SNRPD2 expression-related susceptibility to anti-tumor drugs. This evidence concerns the gene SNRPD2 and neoplasm.